Evidence map›Paper›PMID 39611334›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Enhancing collaboration between academia and industry in kidney disease research.

Robert J Unwin, Benjamin Challis, Iain MacPhee, Pernille B L Hansen, Rachel Jones, Alan Salama, Jonathan Barratt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert J UnwinAstraZeneca Biopharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Cambridge, UK and Gothenburg, Sweden.
Benjamin ChallisAstraZeneca Biopharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Cambridge, UK and Gothenburg, Sweden.
Iain MacPheeAstraZeneca Biopharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Cambridge, UK and Gothenburg, Sweden.
Pernille B L HansenAstraZeneca Biopharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Cambridge, UK and Gothenburg, Sweden.
Rachel JonesDepartment of Medicine, University of Cambridge, Cambridge, UK.
Alan SalamaUCL Centre for Kidney and Bladder Health, University College London, London, UK.
Jonathan BarrattJohn Walls Renal Unit, University of Leicester, Leicester, UK.

Funding

CHIESI
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39611334
PMCPMC12209843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.